| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |